Convergence Investment Partners, LLC - GENOMIC HEALTH INC ownership

GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 135 filers reported holding GENOMIC HEALTH INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Convergence Investment Partners, LLC ownership history of GENOMIC HEALTH INC
ValueSharesWeighting
Q2 2019$226,000
-75.5%
3,892
-70.4%
0.06%
-72.6%
Q1 2019$923,000
+78.2%
13,170
+63.7%
0.20%
+68.9%
Q4 2018$518,000
+9.7%
8,044
+19.8%
0.12%
+24.0%
Q3 2018$472,000
-56.5%
6,715
-78.9%
0.10%
-34.2%
Q4 2017$1,086,000
-4.9%
31,756
-10.8%
0.15%
-9.9%
Q3 2017$1,142,000
+1.2%
35,598
+2.7%
0.16%
-1.8%
Q2 2017$1,129,000
-9.8%
34,670
-12.7%
0.16%
-6.2%
Q1 2017$1,251,00039,7350.18%
Other shareholders
GENOMIC HEALTH INC shareholders Q1 2018
NameSharesValueWeighting ↓
Baker Brothers Advisors 13,668,866$353,955,0003.71%
Camber Capital Management LP 2,458,100$63,652,0003.08%
Ghost Tree Capital, LLC 200,000$5,179,0001.50%
Tributary Capital Management, LLC 206,291$5,342,0000.78%
Motley Fool Asset Management LLC 131,935$3,416,0000.74%
CORRADO ADVISORS, LLC 40,695$1,054,0000.68%
Broadfin Capital, LLC 270,400$7,002,0000.68%
ACUTA CAPITAL PARTNERS, LLC 48,800$1,264,0000.61%
Motley Fool Wealth Management, LLC 123,018$3,186,0000.35%
TFS CAPITAL LLC 61,773$1,600,0000.29%
View complete list of GENOMIC HEALTH INC shareholders